Safety and dose relationship of recombinant human activated protein C for coagulopathy in severe sepsis.

Bernard GR, Ely EW, Wright TJ, Fraiz J, Stasek JE, Russell JA, Mayers I, Rosenfeld BA, Morris PE, Yan SB, Helterbrand JD
Crit Care Med. 2001 29 (11): 2051-9

PMID: 11700394 · DOI:10.1097/00003246-200111000-00003

MeSH Terms (16)

Critical Care Disseminated Intravascular Coagulation Dose-Response Relationship, Drug Double-Blind Method Drug Administration Schedule Female Fibrin Fibrinogen Degradation Products Hospital Mortality Humans Infusions, Intravenous Male Middle Aged Protein C Recombinant Proteins Sepsis Severity of Illness Index

Connections (1)

This publication is referenced by other Labnodes entities: